Neurology therapeutics Market | Neurology Devices Market
Wearable Devices: Weighing the Potential Benefits and Pitfalls of the Innovative Wearable Products
pharma-news-for-algernon-pieris-gaumard-hekka-labs
Algernon’s NP-120 (ifenprodil); Pieri...

Algernon receives positive FDA feedback on Phase IIb chronic cough trial The US Food and Drug Administratio...

pharma-news-for-noxxon-nuvalent-stryker-exact-sciences
Noxxon’s NOX-A12 clinical trial; Exac...

Noxxon continues enrolment in a glioblastoma therapy trial Noxxon Pharma continues subject enrolment in the...

pharma-news-for-biogen-eisai-quidel-accutar-boehringer
Biogen-Eisai’s Aduhelm; Quidel ...

Biogen-Eisai's potential Aduhelm sequel drug secured speedy review by FDA Biogen and Eisai’s Alzheimer’s di...

medtech-news-for-boston-scientific-bd-roche-linus-helioliver
Boston Scientific’s MODULAR CRM System; Restore Medical’s ContraBand clinical trial r...

Boston Scientific initiates trial to evaluate industry's first Modular CRM System  On December 02, 2021, Boston Scientific Corporation started the MODULAR ATP clinical trial to examine the...


pharma-news-for-aslan-iqvia-reata-recordati-eusa
Aslan Pharma – IQVIA collaboration; Reata’s kidney drug bardoxolone; Alzheimer’s Dise...

Aslan Pharmaceuticals enters into a strategic collaboration with IQVIA   ASLAN Pharmaceuticals announced the appointment of IQVIA Biotech, a provider of analytics, technology solution...


Neuromodulation-Devices-Migraine
Neuromodulation Devices Observed to Reshape the Migraine Treatment Dynamics

Migraine is the most commonly encountered disabling disorder that can be featured as attacks of severe, unilateral, and a pulsating form of headache composed of symptoms such as photophobia, phono...


pharma-news-for-bluebird-bio-fda-twist-bioscience-sosei-heptares
Bluebird bio may get gene therapy approved in the US; Neurocrine pens $2.6B pact with Sosei Hepta...

Bluebird bio may finally get a gene therapy approved in the US Bluebird bio may get gene therapy approved in the US. The Cambridge, MA biotech declared that the FDA had accepted and given prior...


medtech-news-and-updates-for-abbott-ivantis-medtronic-alung-appliedvr-orthalign
Abbott’s Pacemaker System; Ivantis’s Hydrus Microstent; Medtronic’s PillCam Small Bowel 3; ...

J&J intends to split into two companies, separating consumer products and pharmaceutical businesses  On November 12, 2021, Johnson & Johnson announced its plans to split the Company’s C...


medtech-news-for-tectraum-vektor-medtronic-alcon-philips-sight-sciences
TecTraum’s pro2cool receives Breakthrough Device Designation; Vektor Obtains FDA Clearance for vM...

TecTraum’s pro2cool® receives FDA Breakthrough Device Designation for the Concussions treatment   On November 03, 2021, TecTraum Inc., working to develop the world’s first point-of-care treatme...


Editor's Pick
22 Healthcare Trends & Innovations to Watch in 2022 and Beyond

With the advent of new-age healthcare industry trends that are evident as of now, there...

Assessment of Key Products that Got FDA Approval in Second Half (H2) of 2021

Although COVID-19 continued to dominate headlines in 2021, pharmaceutical companies did...

Analyzing the Key Trends Driving the Biosimilar Market Growth

The Biosimilars market is growing at a breakneck pace. The biosimilar market provides a...

CAR-T Cell Therapy aka Miraculous Technology: Mapping the Market, Approved Th...

Chimeric antigen receptor T-cell (CAR T) therapies are shown to have transformative pot...

Myelodysplastic Syndromes (MDS): Key Pharma Players Unveiling Updated Finding...

There has been limited progress in the approval of novel agents in MDS. It has been a l...